companydata.dkBIODANE PHARMA A/S: Financial statements 2016
CVR: 28310102
BIODANE PHARMA A/S (CVR 28310102) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 747,313 and a net result of DKK 32,975 compared with DKK -253,036 the year before. That is an increase of 70.6% compared with the year before. Equity amounted to DKK 766,517. The solvency ratio was 80.9%. The company had 1 employee in the financial year.
- Gross Profit
- 747,313 kr.
- Profit/Loss
- 32,975 kr.
- Equity
- 766,517 kr.
- Total Assets
- 947,244 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 747 t. | 33 t. | 767 t. | 1 |
| 2015 | - | 438 t. | -253 t. | 734 t. | - |
| 2014 | - | 279 t. | -250 t. | 987 t. | - |
| 2013 | - | 106 t. | -977 t. | -263 t. | - |
| 2012 | - | 384 t. | 8 t. | 714 t. | - |
How creditworthy is BIODANE PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
BIODANE PHARMA A/S has published its annual report for 2015. Gross profit came to DKK 437,995, and the net result was DKK -253,036.
About BIODANE PHARMA A/S
BIODANE PHARMA A/S is a Danish company of the type Aktieselskab based in Gesten, founded in 2004. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Gunner Kreutzer Jakobsen. The company is owned by BIODAN A/S. In 2025, the company reported a gross profit of DKK 2,534,166 and a net result of DKK 182,862 compared with DKK 1,651,356 the year before. Equity amounted to DKK 2,505,002.